| http://www.w3.org/ns/prov#value | - vate placement would, subject to the satisfaction of customary closing conditions, generate gross proceeds to GTXI of $21,272,455.42, or approximately $1.77625 per unit.GTXI is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, including treatments for prostate and breast cancer, cancer supportive care, includi
|
